Genomma Lab Internacional SAB de CV

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: MX01LA010006
MXN
14.78
-0.32 (-2.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
4,190.62
4,016.97
4,441.43
4,676.44
4,406.33
4,665.57
5,092.51
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,190.62
4,016.97
4,441.43
4,676.44
4,406.33
4,665.57
5,092.51
Raw Material Cost
1,533.04
1,567.73
1,605.27
1,707.02
1,639.01
1,723.90
1,820.51
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
285.90
252.89
267.18
257.33
270.57
434.11
310.31
Selling and Distribution Expenses
1,784.61
1,588.07
1,930.44
1,965.76
1,807.86
1,949.96
2,160.05
Other Expenses
-28.59
-25.29
-26.72
-25.73
-27.06
-43.41
-31.03
Total Expenditure (Excl Depreciation)
3,317.64
3,155.80
3,535.72
3,672.78
3,446.86
3,673.87
3,980.56
Operating Profit (PBDIT) excl Other Income
873
861.2
905.6999999999999
1003.7
959.5
991.7
1112
Other Income
57.03
-40.21
-30.98
-189.48
12.28
41.55
130.62
Operating Profit (PBDIT)
1,020.71
1,011.04
970.01
906.21
1,068.76
1,154.45
1,331.10
Interest
285.90
252.89
267.18
257.33
270.57
434.11
310.31
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
2,657.59
2,449.24
2,836.16
2,969.41
2,767.32
2,941.67
3,272.00
Depreciation
90.71
190.08
95.27
92.04
97.02
121.19
88.53
Profit Before Tax
644.11
568.07
607.55
556.84
701.17
599.15
932.26
Tax
149.46
248.43
173.49
201.87
202.45
125.66
272.20
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
494.65
319.64
434.07
354.97
498.72
473.49
660.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
494.65
319.64
434.07
354.97
498.72
473.49
660.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
494.65
319.64
434.07
354.97
498.72
473.49
660.06
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
11,715.17
11,118.04
11,005.56
11,235.39
11,108.86
10,884.86
11,153.04
Earnings per share (EPS)
0.51
0.33
0.44
0.36
0.51
0.48
0.7
Diluted Earnings per share
0.51
0.33
0.44
0.36
0.51
0.48
0.7
Operating Profit Margin (Excl OI)
20.83%
21.44%
20.39%
21.46%
21.77%
21.26%
21.84%
Gross Profit Margin
17.53%
18.87%
15.82%
13.88%
18.11%
15.44%
20.04%
PAT Margin
11.8%
7.96%
9.77%
7.59%
11.32%
10.15%
12.96%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 4.32% vs -9.56% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 54.76% vs -26.38% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is -8.32% vs 5.01% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 13.05% vs -5.35% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

Compare Quarterly Results Of Genomma Lab Internacional SAB de CV With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(MXN)
Change(%)
Net Sales
4,190.62
0
4,190.62
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,190.62
0
4,190.62
Raw Material Cost
1,533.04
0
1,533.04
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
285.90
0
285.90
Selling and Distribution Expenses
1,784.61
0
1,784.61
Other Expenses
-28.59
0.00
-28.59
Total Expenditure (Excl Depreciation)
3,317.64
0
3,317.64
Operating Profit (PBDIT) excl Other Income
872.98
0.00
872.98
Other Income
57.03
0
57.03
Operating Profit (PBDIT)
1,020.71
0
1,020.71
Interest
285.90
0
285.90
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
2,657.59
0
2,657.59
Depreciation
90.71
0
90.71
Profit Before Tax
644.11
0
644.11
Tax
149.46
0
149.46
Provisions and contingencies
0
0
0.00
Profit After Tax
494.65
0
494.65
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
494.65
0
494.65
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
494.65
0
494.65
Equity Capital
0
0
0.00
Face Value
0.00
0
0.00
Reserves
11,715.17
0
11,715.17
Earnings per share (EPS)
0.51
0
0.51
Diluted Earnings per share
0.51
0
0.51
Operating Profit Margin (Excl OI)
20.83%
0%
0.00
20.83%
Gross Profit Margin
17.53%
0%
0.00
17.53%
PAT Margin
11.80%
0%
0.00
11.80%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 419.06 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 4.32% vs -9.56% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -4.90% vs 4.98% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 49.46 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 54.76% vs -26.38% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -0.82% vs 15.41% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 96.37 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is -8.32% vs 5.01% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -8.78% vs 11.74% in Mar 2025

Quarterly - Interest
Interest 28.59 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 13.05% vs -5.35% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 5.65% vs 18.53% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.83%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025